Geron Corporation (GERN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.27+0.01 (+0.44%)
At close: 4:00 PM EDT

2.27 0.00 (0.00%)
After hours: 6:56 PM EDT

People also watch:
STEMARIAINCYEXELCTIC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.30
Prev Close2.26
Bid2.27 x 5000
Ask2.39 x 1000
Day's Range2.25 - 2.35
52wk Range1.84 - 5.30
1y Target EstN/A
Market Cap361.25M
P/E Ratio (ttm)283.75
Beta3.76
Volume1,067,472
Avg Vol (3m)1,824,560
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Geron Corp. : September 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Geron Corp. Here are 5 ETF’s with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Investopedia5 days ago

    Global Licensing Deal Spikes Geron Stock (GERN, JNJ)

    Building upon an existing 2014 agreement, Geron and Jenssen have struck a renewed global partnership on multiple products.

  • Johnson & Johnson (JNJ)’s Janssen Builds On Partnership With Geron Corporation (GERN)
    Insider Monkey7 days ago

    Johnson & Johnson (JNJ)’s Janssen Builds On Partnership With Geron Corporation (GERN)

    Janssen Pharmaceuticals, a subsidiary of the giant manufacturing company, Johnson & Johnson (NYSE:JNJ) has expanded the current partnership with the long-beleaguered Geron Corporation (NASDAQ:GERN). The newly formed partnership is for the worldwide and exclusive rights to the biotech’s oligonucleotide backbone chemistry and the novel amides for ribonucleic acid interference or RNAi. The latter is used in […]